REFERENCES
- Amighi K., Timmermans J., Puigdevall P., Baltes E., Moes A. J. Peroral sustained-release film coated pellets as a means to overcome physicochemical and biological drug related problems. I. In vitro development and evaluation. Drug Dev. Ind. Pharm. 1998; 24: 509–515
- Dashevsky A., Kolter K., Bodmeier R. pH-independent release of a basic drug from pellets coated with the extended release polymer dispersion Kollicoat SR 30 D and the enteric polymer dispersion Kollicoat MAE 30 DP. Eur. J. Pharm. Biopharm. 2004; 58: 45–49
- Dimitrov M., Lambov N. Study of verapamil hydrochloride release from compressed hydrophilic Polyox-Wsr tablets. Int. J. Pharm. 1999; 189: 105–111
- Gabr K. E. Effect of organic acids on the release patterns of weakly basic drugs from inert sustained release matrix tablets. Eur. J. Pharm. Biopharm. 1992; 38: 199–202
- Gohel M. C., Patel T. P., Bariya S.H. Studies in preparation and evaluation of pH-independent sustained release matrix tablets of verapamil HCl using directly compressible Eudragits. Pharm. Dev. Technol. 2003; 8: 323–333
- Kohri N., Yatabe H., Iseki K., Miyazaki K. A new type of a pH-independent controlled release tablet. Int. J. Pharm. 1991; 68: 255–264
- Kranz H., Guthmann C., Wagner T., Lipp R., Reinhard J. Development of a single unit extended release formulation for ZK 811 752, a weakly basic drug. Eur. J. Pharm. Sci. 2005; 26: 47–53
- Merck & Co. Inc. Merck Index. Whitehouse Station, , NJ 2001; XII
- Streubel A., Siepmann J., Dashevsky A., Bodmeier R. pH-independent release of a weakly basic drug from water-soluble matrix tablets. J. Control. Release 2000; 67: 101–110
- Takka S., Rajbhandri S., Sakr A. Effect of anionic polymers on the drug release of propranolol hydrochloride from matrix tablets. Eur. J. Pharm. Biopharm. 2001; 52: 75–82
- Tatavarti A. S., Mehta K. A., Augsburger L. L., Hoag S. W. Influence of methacrylic and acrylic acid polymers on the release performance of weakly basic drugs from sustained release hydrophilic matrices. J. Pharm. Sci. 2004; 93: 2319–2331
- Thoma K., Knott F. Retardierung schwach basischer Arzneistoffe. Pharm. Ind. 1991; 53: 686–690
- Thoma K., Ziegler I. The pH-independent drug release of fenoldopam from pellets coated with insoluble film coats. Eur. J. Biopharm. 1998; 46: 105–113
- Thoma K., Zimmer T. Retardation of weakly basic drugs with diffusion tablets. Int. J. Pharm. 1990; 58: 197–202
- Timmins P., Delargy A. M., Howard J.R. Optimization and characterization of a pH-independent extended-release hydrophilic matrix tablet. Pharm. Dev. Technol. 1997; 2: 25–31
- Varma M. V.S., Kaushal A. M., Garg S. Influence of micro-environmental pH on the gel layer behavior of a basic drug from various hydrophilic matrices. J. Contr. Release 2005; 103: 499–510
- Venkatesh G. M. Development of controlled-release SK&F 82526-J buffer bead formulations with tartaric acid as the buffer. Pharm. Dev. Technol. 1998; 3: 477–485